Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 6,868 | 90,273 | 0 | 0 | 0 |
| Cost of Goods | 400 | N/A | N/A | N/A | N/A |
| Gross Profit | 6,468 | 90,273 | N/A | N/A | N/A |
| Operating Expenses | 714,992 | 483,511 | 273,155 | 160,163 | 94,650 |
| Operating Income | -708,124 | -393,238 | -273,155 | -160,163 | -94,650 |
| Other Income | 27,886 | 20,356 | 3,035 | 1,176 | 155 |
| Pre-tax Income | -680,238 | -372,882 | -270,120 | -158,987 | -94,495 |
| Net Income Continuous | -680,238 | -372,882 | -270,120 | -158,987 | -94,495 |
| Net Income | $-680,238 | $-372,882 | $-270,120 | $-158,987 | $-94,495 |
| EPS Basic Total Ops | -13.38 | -8.08 | -7.09 | -4.75 | -3.40 |
| EPS Basic Continuous Ops | -13.38 | -8.08 | -7.09 | -4.75 | -3.40 |
| EPS Diluted Total Ops | -13.38 | -8.08 | -7.09 | -4.75 | -3.40 |
| EPS Diluted Continuous Ops | -13.38 | -8.08 | -7.09 | -4.75 | -3.40 |
| EPS Diluted Before Non-Recurring Items | -13.38 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-712,807 | $-401,987 | $-272,917 | $-159,596 | $-94,535 |